Lamotrigine Tablet, Extended Release
Product Images NDC 82804-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 82804-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Image Clinicalstudy1 Partialonsetseizure)

Figure (Image Clinicalstudy1 Partialonsetseizure)
A line graph comparing responder rates of patients taking Lamotrigine Extended-Release Tablets versus placebo. The x-axis shows the percent of patients, decreasing from 100 to 0, while the y-axis shows responder rate from worsening (-100%) to improvement (100%). Solid and dashed lines represent the Lamotrigine and placebo groups, respectively.*
FDA Label Image

1 (Image Clinicalstudy2 Partialonsetseizure)

1 (Image Clinicalstudy2 Partialonsetseizure)
A responder rate plot comparing Lamotrigine extended-release tablets to placebo, showing percentages of patients on the horizontal axis and responder rates (equal or greater improvement vs worsening) on the vertical axis. The graph includes two lines, one for placebo and one for Lamotrigine, illustrating differences in response rates.*
FDA Label Image

82804-105-30 (Label 50mg)

82804-105-30 (Label 50mg)
Lamotrigine 50 mg extended-release oral tablets label by Proficient Rx LP. The label states the product contains 30 E.R. tablets to be taken once daily, with each film-coated tablet containing 50 mg of lamotrigine. Tablets are described as light green to green, round, biconvex, with "340" debossed on one side and "50" on the other. Manufactured by Torrent Pharmaceuticals Ltd., India.*
FDA Label Image

Image (Logo mg)

FDA Label Image

Logo (Logo Pi)

FDA Label Image

1 (Structure)

1 (Structure)
Chemical structure diagram of Lamotrigine, showing its molecular arrangement including chlorine and amino groups. The image depicts bonds and atoms relevant to the active ingredient Lamotrigine in the product.*
FDA Label Image

Image (Tabletsappearence)

Image (Tabletsappearence)
Data table depicting Lamotrigine tablets in various strengths (25 mg, 50 mg, 100 mg, 200 mg) with a visual representation of each tablet's upper and lower face, including imprint codes and color descriptions ranging from light yellow to blue.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.